...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2018
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Zenith presents in Amsterdam a week from today at BIO-Europe. A great opportunity to show updated trial data......and maybe other news around the same time? They can't stay hush hush forever.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply